Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - lidocaine hydrochloride, epinephrine bitartrate - solution for injection - 2 (1:200,000 %v/v - amides

Malta - English - Medicines Authority

astrazeneca ab - lidocaine 10 mg - cutaneous spray

Ireland - English - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - lidocaine - oromucosal spray, solution - 10 milligram(s)/dose - lidocaine

Ireland - English - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - adrenaline tartrate; lidocaine hydrochloride - solution for injection - 2 (1:200,000 percent volume/volume - amides; lidocaine, combinations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - lidocaine - spray - 10mg/1actuation

Malta - English - Medicines Authority

aspen pharma trading limited 3016 lake drive city west businees campus dublin 24, ireland - lidocaine - cutaneous spray - lidocaine 10 mg - anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous - topical gel - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid methyl hydroxybenzoate methylcellulose propyl hydroxybenzoate purified water sodium hydroxide active: lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid hypromellose methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium hydroxide - xylocaine 2% jelly is indicated as a surface anaesthetic and lubricant for: · the male and female urethra during cystoscopy, catheterisation, exploration by sound and other endourethral procedures. · nasal and pharyngeal cavities in endoscopic procedures such as gastroscopy and bronchoscopy. · during proctoscopy and rectoscopy. · tracheal intubation. · to relieve pain after circumcision in children.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - lidocaine - solution - lidocaine 10 mg / 0.1 ml - lidocaine - lidocaine - surface anaesthesia in dental practice otorhinolaryngology, obstetric and anaesthesiology.

United States - English - NLM (National Library of Medicine)

cardinal health - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 20 mg in 1 ml